Airing weekdays at 7:30 A.M. on

Airing weekdays at 7:30 A.M. on

Media Contact
Pam Steele-Unger
O2 Media
(954) 691-1102

The Balancing Act® Talks Joining the Financial Literacy Club; Goes Behind the Mystery of Severe Malignant Osteopetrosis

Show will feature how women can increase their financial literacy; plus discuss a rare and genetic bone disease that afflicts babies and young children, on July 28 Show on Lifetime®

(POMPANO BEACH, Fla. – PR LOG – July 27, 2015) Award-winning morning show The Balancing Act® will feature what women need to know before getting a loan; plus dedicate a segment on the rare and genetic disease severe malignant osteopetrosis as part of the “Behind the Mystery: Rare and Genetic Diseases” programming on Tuesday, July 28 at 7:30 a.m. (ET/PT) on Lifetime®.  Tune in as The Balancing Act hosts help jump start the day with lively conversations, and trusted information to empower a woman’s life.

Don’t miss these featured segments taking center stage on The Balancing Act:

  • Join the Financial Literacy Club – with Springleaf Financial

Do you wonder why the rates you pay for your mortgage, car loans or even your insurance are higher than your friend’s? Do you know what your credit score is? You’ll definitely want to watch this segment of The Balancing Act and join the “Financial Literacy” club!  Women everywhere are starting to realize that knowing their credit score and having a budget is empowering…it puts you in a stronger position to negotiate with lenders, and you’ll know what you need and can afford.   Learn some of the basics and how Springleaf helps people like you increase their financial literacy and take charge of their finances.

For more information, please visit:


  • Severe Malignant Osteopetrosis Awareness

We’ve all heard of osteoporosis –but have you heard of severe malignant osteopetrosis?  Unless you’re one of only 200 families in the entire country dealing with this devastating diagnosis… you probably haven’t.  Severe malignant osteopetrosis is a very rare bone disease that afflicts babies and young children. Join Dr. Paul Orchard, one of the experts in the U.S. in the use of bone marrow stem cell transplants needed by osteopetrosis patients, as he describes what osteopetrosis is and current treatment options. He will be joined on set by Paul and Barbara Wersten, whose son Ryan was diagnosed with malignant infantile osteopetrosis at 3 weeks old. They formed a support organization called the Ryan Wersten MIOP Foundation which provides a resource to other patient families.

About The Balancing Act®

Entering its 8th season, The Balancing Act continues to empower women in all aspects of their lives. The mission at The Balancing Act is simple – to help today’s modern woman balance it all by bringing them positive solutions to enrich and empower them. Entertaining, educational and trusted by women, viewers can tune in to America’s premier morning show The Balancing Act on weekday mornings Monday through Friday at 7:30 am (ET/PT) on Lifetime television. For additional information or to view a segment visit:
For more information regarding O2 Media, Branded Entertainment, Product Placement and TV Brand Integration go to:

Join the Conversation!

Like us on Facebook at:
Follow us on Twitter at:
Watch us on YouTube at:

Health, Wealth, Beauty, and Business

Bringing the best tips from the experts in Atlanta in business, beauty, wealth management, child healthcare, car shopping, and more. Each year, Atlanta’s Women’s Entrepreneurship Initiative selects 15 local female entrepreneurs for a 15-month business training program. We meet women who have grown their companies, created jobs, and broke through the glass ceiling. With some […]

iMCD is the deadliest subtype of Castleman disease. Approximately one third of patients die within five years of diagnosis, and another third die within 10 years if not treated.

There are no effective treatment options for people with unresectable or metastatic chondrosarcoma despite many attempts by multiple pharmaceutical companies over the past few decades.